AGILQ (AGILQ) Stock Price & Analysis
AGILQ (AGILQ) rose 0.00% to USD 0 as of June 10, 2026 at 03:15 UTC, according to Nexqual real-time market data.
AGILQ last closed at USD 0; the session ranged USD 0–0 on volume of 23,311 shares. Market capitalization is $5,240, with a 52-week range of USD 0–0.5 (PNK). Source: Nexqual, June 10, 2026 at 03:15 UTC.
Key Statistics (as of June 10, 2026 at 03:15 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.5 |
| Volume | 23,311 shares |
| Market Cap | $5,240 |
| Exchange | PNK |
Technical Analysis (AGILQ)
Nexqual's technical model rates AGILQ "STRONG SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:15 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (AGILQ)
Wall Street analysts rate AGILQ "None", per Nexqual as of June 10, 2026 at 03:15 UTC.
| Consensus Rating | None |
|---|
Earnings (AGILQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-06-30 | USD -0.13 vs est -0.04 ▼ miss |
| 2023-03-31 | USD -0.09 vs est -0.06 ▼ miss |
| 2022-12-31 | USD 0.03 vs est -0.12 ▲ beat |
| 2022-09-30 | USD -0.01 vs est -0.06 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:15 UTC.
Financials & Fundamentals (AGILQ)
| Total Revenue | $166.62M |
|---|---|
| Revenue Growth (YoY) | -17.00% |
| Gross Margin | +32.63% |
| Operating Margin | -18.58% |
| Profit Margin | -41.20% |
| ROE | -118.43% |
| Debt / Equity | 325.19 |
| Current Ratio | 0.31 |
| Total Cash | $3.78M |
| Total Debt | $95.07M |
| Free Cash Flow | $10.83M |
Source: Nexqual, June 10, 2026 at 03:15 UTC.
Financial Health Score (AGILQ)
Nexqual rates AGILQ's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:15 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 33%, operating -19% |
| Balance Sheet | Critical — $4M cash vs $95M debt |
| Cash Flow | Solid — FCF $11M, 6% margin |
| Efficiency | Critical — ROE -118%, ROA -4.7% |
Ownership (AGILQ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 52.40M |
| Float | 49.98M |
| Short % of Float | +4.45% |
Source: Nexqual, June 10, 2026 at 03:15 UTC.
Leadership (AGILQ)
AGILQ is led by Shantala Sadananda, Chief Executive Officer, per Nexqual as of June 10, 2026 at 03:15 UTC.
| Chief Executive Officer | Shantala Sadananda |
|---|---|
| President | Manuel Senderos Fernandez (age 51) |
| Senior VP of LATAM Market Unit & Director | Garduno Gonzalez Elizondo-Mauricio (age 56) |
| Director and VP of M & A | Diego Zavala (age 62) |
| Chief Financial & Operations Officer | Kevin Walmsley |
Major Backers & Investors (AGILQ)
Notable institutional backers of AGILQ include Virtus Family Office LLC , according to Nexqual as of June 10, 2026 at 03:15 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Virtus Family Office LLC | 0.32% |
Source: Nexqual, June 10, 2026 at 03:15 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma, Inc. | USD 0 | ▲ 0% |
| ACBM | ACRO BIOMEDICAL CO LTD | USD 0.03 | ▲ 0% |
| INLB | ITEM 9 LABS CORP | USD 0 | ▲ 0% |
| GKIN | Guskin Gold Corp. | USD 0 | ▲ 0% |
| GMVDF | G Medical Innovations Holdings | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:15 UTC. This page is informational and not investment advice.